Categories: News

iResearch Atlanta expands clinical research options after COVID-19 inspires more people in the community to participate

ATLANTA, June 9, 2021 /PRNewswire/ — iResearch Atlanta welcomes new investigators and expands its operations to serve more patients in phase I-IV clinical trials, the ability to continue researching new and innovative therapies including COVID-19.  

iResearch Atlanta, co-founded in 2010 by Heather Beitz, Chief Executive Officer and Sara Castle, Chief Operations Officer has recently grown its exceptional team of Investigators. With seven renowned, local physicians, iResearch Atlanta will continue as a KOL (Key Opinion Leader) in several therapeutic indications.

Led by Kimball A. Johnson, M.D., Medical Director, her team of Principal investigators and their specialties include:

Eric A. Awad, M.D.
Board Certified Neurology

Mary Burns, M.D.
Board Certified Psychiatry

Gayle L. Goldstein, M.D.,
Board Certified Ophthalmology

Saundra A. Maass-Robinson, M.D.,
Board Certified Psychiatry

Jessica C. McCoun, M.D.,
Board Certified Anesthesiology

Simone Whitmore, M.D.
Board Certified OBGYN

In addition, to the growing medical team, iResearch Atlanta is expanding its local footprint to include several locations in downtown Decatur, GA.

iResearch Atlanta is opening a new, 10,000 square foot clinical research unit! This innovation-inspired facility increases our Psychedelic and Consciousness Research and Phase I capabilities.

iResearch Atlanta remains committed to supporting our community and providing invaluable services to individuals experiencing a mental health crisis. In metro Atlanta and the state of Georgia, many people with serious mental illnesses do not have access to the support and treatment they need for sustainable recovery. iResearch Atlanta is proud to help patients recover from crisis and maintain their wellness.

iResearch Atlanta locations and capabilities below:

  • Outpatient research clinic with over 17,000 square feet
    • 250 E. Ponce de Leon Avenue, 8th Floor, Decatur, GA 30030
  • Outpatient memory research unit with over 3,500 square feet
    • 250 E. Ponce de Leon Avenue, Suite 300, Decatur, GA 30030
  • Outpatient infections disease research unit (COVID-19)
    • 820 Church Street, Decatur, GA 30030
  • Inpatient clinical research unit
    • 755 Commerce Drive, 1st Floor, Decatur, GA 30030
      • Certified Sleep Lab
      • Adult dedicated wing with 30 inpatient beds
      • Pediatric dedicated wing with 10 inpatient beds
      • Psychedelic dedicated wing with 4 tranquil rooms  

To learn more about our clinical research site, capabilities, and initiatives, visit the website at http://www.iResearchAtlanta.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/iresearch-atlanta-expands-clinical-research-options-after-covid-19-inspires-more-people-in-the-community-to-participate-301309472.html

SOURCE iResearch Atlanta

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

43 minutes ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

4 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

4 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

4 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

4 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

4 hours ago